BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 23395491)

  • 1. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
    Levy E; Godet J; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
    Bergman R
    Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Pseudolymphomas.
    Romero-Pérez D; Blanes Martínez M; Encabo-Durán B
    Actas Dermosifiliogr; 2016 Oct; 107(8):640-51. PubMed ID: 27289134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous pseudolymphomas: classification and differential diagnosis.
    Rijlaarsdam JU; Willemze R
    Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
    Han B; Liu H; Wang H
    Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic immunohistology: cutaneous lymphomas and pseudolymphomas.
    Cerroni L; Kerl H
    Semin Cutan Med Surg; 1999 Mar; 18(1):64-70. PubMed ID: 10188844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous pseudolymphomas.
    Ploysangam T; Breneman DL; Mutasim DF
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):877-95; quiz 896-7. PubMed ID: 9631994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features.
    Kazakov DV; Burg G; Kempf W
    Cesk Patol; 2002 Oct; 38(4):147-54. PubMed ID: 12629860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tattoo ink-related cutaneous pseudolymphoma: a rare but significant complication. Case report and review of the literature.
    Marchesi A; Parodi PC; Brioschi M; Marchesi M; Bruni B; Cangi MG; Vaienti L
    Aesthetic Plast Surg; 2014 Apr; 38(2):471-8. PubMed ID: 24570180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who sends what: a comparison of dermatopathology referrals from dermatologists, pathologists and dermatopathologists.
    Goldenberg G; Camacho F; Gildea J; Golitz LE
    J Cutan Pathol; 2008 Jul; 35(7):658-61. PubMed ID: 18201232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerase chain reaction-based clonality analysis of cutaneous B-cell lymphoproliferative processes.
    Melotti CZ; Amary MF; Sotto MN; Diss T; Sanches JA
    Clinics (Sao Paulo); 2010; 65(1):53-60. PubMed ID: 20126346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
    Cerroni L; Goteri G
    Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-associated lymphoma and pseudolymphoma: recognition and management.
    Albrecht J; Fine LA; Piette W
    Dermatol Clin; 2007 Apr; 25(2):233-44, vii. PubMed ID: 17430760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous pseudolymphomas and pseudoclonality of lymphoid infiltrates].
    Quatresooz P; Piérard-Franchimont C; Devillers C; Piérard GE
    Rev Med Liege; 2009 Nov; 64(11):581-6. PubMed ID: 20069973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
    Rijlaarsdam JU; Willemze R
    Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic criteria of primary cutaneous B-cell lymphomas and pseudolymphomas.
    Kerl H; Fink-Puches R; Cerroni L
    Keio J Med; 2001 Dec; 50(4):269-73. PubMed ID: 11806505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous pseudolymphomas: inflammatory reactive proliferations.
    Hussein MR
    Expert Rev Hematol; 2013 Dec; 6(6):713-33. PubMed ID: 24191857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.